Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis

Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis

We describe a human nasal epithelial (HNE) organoid model derived directly from patient samples that is well-differentiated and recapitulates the airway epithelium, including the expression of cilia, mucins, tight junctions, the cystic fibrosis transmembrane conductance regulator (CFTR), and ionocyt...

Full description

Bibliographic Details
Main Authors:	Zhongyu Liu, Justin D. Anderson, Lily Deng, Stephen Mackay, Johnathan Bailey, Latona Kersh, Steven M. Rowe, Jennifer S. Guimbellot
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Genes
Subjects:	cystic fibrosis CFTR human nasal epithelial cells organoids biomarker functional assay
Online Access:	https://www.mdpi.com/2073-4425/11/6/603

Similar Items

Personalized Medicine Based on Nasal Epithelial Cells: Comparative Studies with Rectal Biopsies and Intestinal Organoids
by: Iris A. L. Silva, et al.
Published: (2021-05-01)

Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis
by: Duncan E. Keegan, et al.
Published: (2021-04-01)

Rationale and design of the HIT-CF organoid study: stratifying cystic fibrosis patients based on intestinal organoid response to different CFTR-modulators
by: Peter van Mourik, et al.
Published: (2020-06-01)

Early intrahepatic duct defects in a cystic fibrosis porcine model
by: Keyan Zarei, et al.
Published: (2021-07-01)

Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
by: Nikhil T. Awatade, et al.
Published: (2018-12-01)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
by: Paolo Scudieri, et al.
Published: (2020-09-01)

New Therapies to Correct the Cystic Fibrosis Basic Defect
by: Christelle Bergeron, et al.
Published: (2021-06-01)

Lung Microbiome in Cystic Fibrosis
by: Filippo Scialo, et al.
Published: (2021-01-01)

Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells
by: Zsolt Bene, et al.
Published: (2021-05-01)

The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel
by: Ilona Gróf, et al.
Published: (2020-06-01)

A clinical case of cystic fibrosis patient with pathogenic N1303K genotype variant with assessment of the CFTR channel function by intestinal current measurement and forskolin-induced swelling in rectal organoids
by: E. I. Kondratyeva, et al.
Published: (2021-07-01)

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease
by: Vito Terlizzi, et al.
Published: (2021-07-01)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
by: Iwona Pranke, et al.
Published: (2019-02-01)

Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor
by: Argyri Petrocheilou, et al.
Published: (2020-01-01)

Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis
by: Massimo Conese, et al.
Published: (2021-03-01)

Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline
by: Constantin Adams, et al.
Published: (2016-07-01)

A retrospective study of cases diagnosed with cystic fibrosis at a single care center in Syria
by: Raghad Al-Baba, et al.
Published: (2021-06-01)

Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation
by: Onofrio Laselva, et al.
Published: (2019-10-01)

Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
by: Shiferaw D, et al.
Published: (2019-08-01)

Atypical cystic fibrosis diagnosed in a14-year-old boy
by: Iwona Stelmach, et al.
Published: (2016-06-01)

Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
by: Giulia Amico, et al.
Published: (2019-11-01)

High-Dose Ibuprofen in Cystic Fibrosis
by: Larry C. Lands, et al.
Published: (2010-07-01)

Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01)

Fibrosis Quística: mutaciones más frecuentes en la población mundial Cystic fibrosis: more frequent mutations in world population
by: Teresa Collazo Mesa
Published: (2008-06-01)

Molecular and Functional Basis of Cystic Fibrosis in Indian Patients: Genetic, Diagnostic and Therapeutic Implications
by: Rajendra Prasad
Published: (2018-10-01)

Characterization of clinical and genetic spectrum of Chinese patients with cystic fibrosis
by: Keqiang Liu, et al.
Published: (2020-06-01)

Molecular Diagnosis and Genetic Counseling of Cystic Fibrosis and Related Disorders: New Challenges
by: Thierry Bienvenu, et al.
Published: (2020-06-01)

Expression and functional significance of the cystic fibrosis transmembrane conductance regulator (CFTR) in human mast cells
by: Dry, Ren
Published: (2009)

Intestinal Dysfunction in Cystic Fibrosis
by: Vitko, Megan Sue
Published: (2016)

Ouabain mimics low temperature rescue of F508del-CFTR in cystic fibrosis epithelial cells
by: Donglei eZhang, et al.
Published: (2012-10-01)

Analysis of Ivacaftor drug approval for cystic fibrosis patients with gating mutations.
by: Nemirajaiah, S.
Published: (2021-08-01)

The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report
by: J. Dixon Johns, et al.
Published: (2019-07-01)

Genetic Examination of Children Suffering from Cystic Fibrosis
by: Ediba Saračević, et al.
Published: (2005-02-01)

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
by: Isabelle Sermet-Gaudelus, et al.
Published: (2021-07-01)

The Expression and Characterization of Human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Tobacco
by: Witt, William T.
Published: (2014)

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
by: Eyleen de Poel, et al.
Published: (2021-09-01)

Teste da medida da diferença de potencial nasal transepitelial
by: Procianoy, Elenara da Fonseca Andrade
Published: (2015)

Teste da medida da diferença de potencial nasal transepitelial
by: Procianoy, Elenara da Fonseca Andrade
Published: (2015)

Teste da medida da diferença de potencial nasal transepitelial
by: Procianoy, Elenara da Fonseca Andrade
Published: (2015)

THE CLINICAL AND GENETIC CHARACTERISTICS AND OUTCOMES OF MECONIUM ILEUS IN CYSTIC FIBROSIS
by: E. I. Kondratyeva, et al.
Published: (2017-01-01)